In vivo imaging is a well-established and important technique used in basic research and drug discovery & development. Being able to apply artificial intelligence (AI) to image data analysis for AI assisted segmentation and regions of interest (ROI) assignment can greatly advance and accelerate the field of preclinical imaging.
We invite you to participate in our Nimbus AI Pilot program for accelerated analysis of your in vivo imaging data from optical, ultrasound, microCT, PET, MRI, x-ray, or other imaging modalities.
Click on the image below to learn how to participate in this program.
